Intervening With Opioid-Dependent Mothers Living in Poverty: Effects on Mothers' and Infants' Behavioral and Biological Regulation
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Opioid Dependence
- Sponsor
- University of Delaware
- Enrollment
- 200
- Locations
- 1
- Primary Endpoint
- Maternal methylation of oxytocin receptor (OXTR) gene
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
This study will assess the efficacy of the modified Attachment and Biobehavioral Catch-Up (mABC) Intervention, adapted for use with peripartum mothers receiving medication-assisted treatment for opioid use disorder. The investigators expect that mothers who receive the modified Attachment and Biobehavioral Catch-up Intervention will show more nurturing and sensitive parenting and more adaptive physiological regulation than parents who receive a control intervention. The investigators expect that infants whose mothers receive the modified Attachment and Biobehavioral Catch-up will show better outcomes in attachment, behavior, and physiological regulation than infants of parents who receive the control intervention.
Detailed Description
Pregnant mothers will be randomly assigned to receive the modified ABC intervention or the control intervention (modified DEF). Hypotheses relate to parent and child outcomes associated with the intervention. Hypothesis 1: Compared to mothers who receive the control intervention, mothers who receive the mABC intervention will show more nurturing and sensitive parenting, enhanced neural activity during parenting-relevant tasks, and more normative patterns of DNA methylation, autonomic nervous system activity, and cortisol production. Hypothesis 2: Compared to infants of mothers who receive the control intervention, infants of mothers who receive the mABC intervention will show more organized and secure attachment patterns, better behavioral regulation during stressors, more advanced social-emotional development, and more normative patterns of DNA methylation, autonomic nervous system activity, and cortisol production. Hypothesis 3: Enhanced maternal sensitivity will mediate effects of the mABC intervention on improved infant outcomes.
Investigators
Mary Dozier
Professor
University of Delaware
Eligibility Criteria
Inclusion Criteria
- •Opioid-dependent pregnant women in third trimester of pregnancy on medication-assisted treatment
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Maternal methylation of oxytocin receptor (OXTR) gene
Time Frame: Infant age of 12 months
Maternal methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva
Infant methylation of μ-opioid receptor (OPRM1) gene
Time Frame: Infant age of 12 months
Infant methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva
Infant diurnal cortisol production
Time Frame: Infant age of 12 months
Infant diurnal cortisol production will be assessed through salivary cortisol levels collected at waketime and bed-time.
Infant attachment
Time Frame: Infant age of 12 months
Infant attachment will be assessed using the Strange Situation. Coding will be completed using the standard Strange Situation coding scheme (with 4 major categories, with secure preferable).
Infant cognitive development
Time Frame: Infant age of 12 months
Infant cognitive development will be assessed through maternal report on the Ages and Stages Questionnaire. Scores could range from 0-300 with higher scores reflecting higher functioning.
Maternal sensitivity
Time Frame: Infant age of 12 months
The mother will be assessed interacting one-to-one with her infant. Parental sensitivity (a composite of following the child's lead in interactions, providing nurturance when the child is distressed, and showing positive regard) will be assessed using procedures and coding from the assessment used by the NICHD Study of Early Child Care and Youth Development (Brady-Smith et al., 1999). Sensitivity will be assessed on a 5-point scale with higher scores indicating greater sensitivity.
Maternal methylation of μ-opioid receptor (OPRM1) gene
Time Frame: Infant age of 12 months
Maternal methylation will be assessed using direct bisulfite sequencing of DNA extracted from saliva
Maternal parasympathetic nervous system activity during Still Face
Time Frame: Pre-intervention (3rd trimester)
The control of cardiac functions via the vagal nerve, or vagal tone, is an index of parasympathetic activity. It can be measured by heart rate variability associated with respiration or high frequency respiratory sinus arrhythmia (RSA). RSA data will be collected continuously throughout a 15-minute period during the Still Face Procedure using a MindWare Portable Lab system. Greater changes in RSA from baseline to still face considered preferable.
Maternal neural activity (Event related potentials - ERP) - Child emotion task
Time Frame: Infant age of 12 months
Maternal event-related potentials will be assessed while viewing images of children crying, laughing, and showing neutral expressions. The N180 (a negative deflection about 180 ms after the stimuli) will be studied, with a bigger difference between faces will be considered preferable.
Maternal parasympathetic nervous system activity
Time Frame: Infant age of 12 months
The control of cardiac functions via the vagal nerve, or vagal tone, is an index of parasympathetic activity. It can be measured by heart rate variability associated with respiration or high frequency respiratory sinus arrhythmia (RSA). RSA data will be collected continuously throughout a 15-minute period during the Still Face Procedure using a MindWare Portable Lab system. Greater changes in RSA from baseline to still face considered preferable.
Infant parasympathetic nervous system activity
Time Frame: Infant age of 12 months
The control of cardiac functions via the vagal nerve, or vagal tone, is an index of parasympathetic activity. It can be measured by heart rate variability associated with respiration or high frequency respiratory sinus arrhythmia (RSA). RSA data will be collected continuously throughout a 15-minute period during the Still Face Procedure using a MindWare Portable Lab system. Greater changes in RSA from baseline to still face considered preferable.
Maternal neural activity (Event related potentials - ERP) - Reward sensitivity task
Time Frame: Infant age of 12 months
Maternal event-related potentials will be assessed while viewing images from four categories: opioid-related images, baby pictures, positive images, and neutral images. The P300 (a positive deflection about 300 ms after the stimuli) will be studied, with a bigger difference between child and opioid-related images considered preferable.
Infant behavioral regulation
Time Frame: Infant age of 12 months
Behavioral coding of emotion regulation will be conducted from video recordings of the Still Face Paradigm on the Behavioral Regulation Scale, a mild social stressor. Behavior regulation will be coded on a scale called Behavior Regulation. The scores will be continuous with higher scores indicating better regulation (ranging from 1-9).
Maternal neural activity (Event related potentials - ERP) - Own child-other child task
Time Frame: Infant age of 12 months
Maternal event-related potentials will be assessed while viewing photos of their own infants, familiar infants, and unfamiliar infants. The P300 (a positive deflection about 300 ms after the stimuli) will be studied, with a bigger difference between own and other child considered preferable.
Secondary Outcomes
- Maternal substance use(Infant age of 12 months)
- Maternal depression(Infant age of 12 months)
- Maternal executive functioning(Infant age of 12 months)